Stifel lifts Nyxoah stock target to $27 on trial success

Mar 20, 2024 - 05:30

Stifel lifts Nyxoah stock target to $27 on trial success

AMAZON.CA DEALS

AMAZON.CA DEALS

Previous Article

HealthEquity stock gets price target boost to $97 on strong quarter

Jefferies raises Tourmaline Bio stock target to $72 on strong momentum

SHOP AMAZON.CA

SHOP AMAZON.CA

Related Posts

Jefferies sets $6.55 target on Biote with new buy rating

Feb 1, 2024

China's securities watchdog opens ears for proposals to...

Feb 19, 2024

Midday movers: Nvidia, Deckers rise; Intuit, Workday fall

May 24, 2024

Midday movers: Nvidia, iRobot, Coinbase and more

Nov 24, 2023

Array Technologies shares get 'Sector Weight' by KeyBan...

Mar 5, 2024

Mercedes-Benz rejects 'anti-union' allegations after US...

Apr 3, 2024

As an Amazon Partner, I may be compensated if you make a purchase - at no additional cost to you.

TODAY'S DEALS

As an Amazon Partner, I may be compensated if you make a purchase - at no additional cost to you.

SHOP AMAZON.CA